Mamedica is a London, UK-based medical cannabis clinic which was founded in 2021 and launched in 2022 by Jon Robson. [1] It is one of four UK clinics licensed to prescribe and dispense medical cannabis.[ citation needed ]
In August 2022, it published a survey of 4,000 people which found that 60% of British people would consider using cannabis to treat medical conditions, particularly if prescribed by a doctor. [2] [3] A February 2023 survey for Mamedica found a third of respondents would use medical marijuana to help treat depression. [4]
In June 2023, Mamedica announced a strategic UK partnership with Canadian medical cannabis products supplier 4C Labs. [5]
The clinic has reported a 400% increase in patients since it was founded. [6] Robson says the clinic aims "to offer an alternative to conventional medicines to individuals who are struggling with a severe medical condition and desire to regain a sense of normalcy in their daily lives". [7]
Mamedica is a member of the UK's Cannabis Industry Council. [8]
In September 2025, it raised a £4.5M round of funding from Casa Verde Capital. [9]
Since June 2022, 40% of Mamedica's prescriptions have been for mental health conditions, including anxiety, depression, stress, insomnia and post-traumatic stress disorder. [10] In 2023, Mamedica reported an increase in demand from patients suffering from psychiatric conditions and opting to use medical cannabis as a replacement for traditional medication that can cause side effects. [11]
In addition, the clinic prescribes CBD to support patients with menopause symptoms like hot flushes, [12] and the clinic supports patients living with chronic neurological pain, with bespoke cannabis-based prescription medicines (CBPMs) that improve individuals' overall quality of life by reducing symptoms of depression and anxiety. [13]
While more than 89,000 private medical cannabis prescriptions have been made in the UK, there have been fewer than five medical cannabis prescriptions via the NHS. [14] UK legislation states that a prescription for medical cannabis can only be initiated by a specialist consultant on the General Medical Council (GMC) register. [15] Before patients can book a Mamedica consultation, they need to have tried at least two licensed medications or treatments and must not have any history of schizophrenia or psychosis. [16] Patients must provide their medical records and details about their family medical history to mitigate any potential risks of using CBPMs. [16]
Mamedica doctors can prescribe CBPMs including THC, Cannabidiol (CBD) and balanced cannabis profiles and cannabis flower, oil, capsules and cartridges for patients living with chronic conditions. [17] Mamedica's cannabis flower prescriptions are strictly for use in dry-herb vaporisers, devices that let patients heat the flower and inhale its contents as a vapour. [16]